Back
ALX Oncology Holdings, Inc. 10K Form
Sell
34
ALXO
ALX Oncology Holdings, Inc.
Last Price:
$1.42
Seasonality Move:
55.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-18 | 10K | ALXO/ALX Oncology Holdings, Inc. Annual |
| 2020-11-12 | 10Q | ALXO/ALX Oncology Holdings, Inc. Quarterly |
| 2020-08-27 | 10Q | ALXO/ALX Oncology Holdings, Inc. Quarterly |
Receive ALXO News And Ratings
See the #1 stock for the next 7 days that we like better than ALXO
ALXO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-17.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.84 |
| Price / Book: | 1.72 |
Profitability
| EPS (TTM): | -2.02750 |
|---|---|
| Net Income (TTM): | $-108M |
| Gross Margin: | $-872K |
| Return on Equity: | -120.56% |
| Return on Assets: | -85.39% |
ALX Oncology Holdings, Inc. Earnings Forecast
Key ALX Oncology Holdings, Inc. Financial Ratios
-
Per Share Earnings over the last 7 years have been positive in 2 years.
ALX Oncology Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALXO |
| Website: | alxoncology.com |
Debt
| Debt-to-Equity Ratio: | 0.35 |
|---|---|
| Current Ratio: | 2.4 |
| Quick Ratio: | 2.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALXO Technical Analysis vs Fundamental Analysis
Sell
34
ALX Oncology Holdings, Inc. (ALXO)
is a Sell
Is ALX Oncology Holdings, Inc. a Buy or a Sell?
-
ALX Oncology Holdings, Inc. stock is rated a SellThe current ALX Oncology Holdings, Inc. [ALXO] share price is $1.42. The Score for ALXO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.